Liquid biopsies and molecular diagnostic – 3 By Maxime | June 5, 2017 - 22:40 |June 5, 2017 qPCR & NGS Freising 2017 Liquid Biopsy - From Discovery to Clinical Implementation Pantel_GQ2023 Maximizing Metastasis Insights: Using an Integrated Workflow Approach to Achieve Efficient CTC Enrichment with Targeted Enumeration for Versatile Downstream Applications Corner_GQ2023 A Development and Analysis Pipeline for MicroRNA Biomarker Signatures in Molecular Diagnostics Based on Circulating EVs Pfaffl_Biomarker-signature_EV Comparison of Two Digital PCR Systems for the Analysis of Liquid Biopsy Samples of Patients Affected by Lung and Colorectal Cancer Crucitta_GQ2023 Performance Evaluation of RNA Purification Kits and Blood Collection Tubes in the Extracellular RNA Quality Control (exRNAQC) Study Vandesompele_GQ2023 HepatomiR® - MicroRNA Biomarkers of Liver Function: from Discovery to Implementation as a Diagnostic Test to Support Management of Liver Cancer Patients Hackl_GQ2023 New Perspectives for Liquid Profiling of Circulating Nucleic Acids in Clinical Diagnostics Holdenrieder_GQ2023 Two-Tailed PCR for Precision Diagnostics Kubista_two-tailed_GQ2023 Liquid Biopsies: Optimization and Sample Quality Controls for ctDNA Measurements Pallisgaard_GQ2023 Tumour-guided Personalised Sequencing Assays For ctDNA Detection Filges_GQ2023 Novel NGS-based Proteomics Revolutionizes Biomarker Identification in Liquid Biopsies Chlamydas_GQ2023 Use of Synthetic Reference Sequence Spike-In Controls to Increase Reliability of NGS Testing for Actionable Mutations in Circulating Tumor DNA Willey_GQ2023 Clinical Applicability of Circulating Nucleic Acids Heilek_GQ2023 Biological, Structural and Functional Aspects of Circulating Nucleic Acids Bronkhorst_GQ2023 Talks in this Session: Back to other sessions of this symposium Tweet Bookmark the permalink.
